Cerebral arteriopathy in children with neurofibromatosis type 1.
about
Moyamoya Syndrome: A Window of Moyamoya DiseaseMoyamoya disease and syndromes: from genetics to clinical managementCerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.Recent advances in childhood arterial ischemic strokeCurrent proceedings of childhood stroke.Pediatric stroke: the importance of cerebral arteriopathy and vascular malformationsSpectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathwayNf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.Coexistence of Neurofibromatosis Type-1 and MTHFR C677T Gene Mutation in a Young Stroke Patient: A Case ReportNeurofibromatosis type 1 complicated by atypical coarctation of the thoracic aortaCerebral arteriopathy in neurofibromatosis type 1.Giant thrombosed intracavernous carotid artery aneurysm presenting as Tolosa-Hunt syndrome in a patient harboring a new pathogenic neurofibromatosis type 1 mutation: a case report and review of the literature.Arterial ischemic stroke in children: risk factors and etiologies.Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.Neurovascular manifestations of connective-tissue diseases: A review.Genetic and Epigenetic Regulation of Aortic AneurysmsNeurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.Clinical features of subarachnoid hemorrhage in patients with positive cancer history.Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.Young stroke due to vascular anomaly from neurofibromatosis type 1.Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.Ischemic cerebral infarction in a 5-year-old male child with neurofibromatosis type 1.Cerebral vasculopathy in children with neurofibromatosis type 1.Moyamoya syndrome related to neurofibromatosis of type 1: a case report.Increased prevalence of ametropia in children with neurofibromatosis type 1 disease.Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.
P2860
Q26800801-22B1AB8A-F82F-460E-BFFD-69618F7BF7AFQ28086795-66DC813C-E63A-44E0-8C0D-63A063F39F59Q30706016-1A8DF033-BE1D-4E00-A5DD-783E028DF966Q33757823-9FF0F07B-5F45-4079-A10F-1DCD6EF495DAQ33885451-C507D716-FCAA-4D2F-B3E2-B9B1D1CC4CF7Q34572329-28919119-102C-4D52-9E0F-D2845A2245D8Q34703702-0FBCD02B-4456-4EB7-A849-07CB5458D111Q36395077-3065FBF1-BF87-423A-9727-4E1DBC107FA4Q36580738-302E4B86-C822-49F5-88B3-4B12E0E30622Q36608863-4A7B04B8-0224-4738-9267-9D24AD7F99C1Q36692111-1C526AEA-00CC-4460-AB58-F2E90999D548Q36702800-9906E512-9BD9-4F13-8136-BB92F45329B0Q37391278-1EC91D3B-0E92-401F-968C-E43E40FBBAFEQ37514623-69D1FA9A-A0AA-47DD-B639-ECAA7736EC05Q37637900-65835662-46BF-4828-8865-9666FC1A5E0FQ37649834-4AB7AD70-A76D-4654-B6BD-B8500EA68646Q38694212-175A75D0-2D3A-407A-BB14-66EDA82EC34DQ38757104-A712BAE7-0F7F-4392-9DB2-F18E629BA2D7Q38832500-579B28C2-A823-4D4E-B429-8A85802003DBQ39100045-A24B3FA6-F7E8-40CC-B3E0-3D968C32686FQ39707123-561B9539-D88E-44D6-BDAB-E9F9ED990EF1Q40898286-4C5CC3E2-8432-451D-B430-3A75FF94BFA0Q41637594-2E6C8553-6406-4180-B398-3C4A9C6B2CADQ41867900-21209A26-543D-44E4-BC7A-2F0251F6F17BQ48302882-83D936FD-1AD1-4D8D-824A-19194D2D94AFQ48524115-AAE6A834-1018-472E-A5C3-B125F260D95FQ48549730-CE08540D-3940-44FC-B4BE-E60E09C62637Q48605856-DEE0892D-AA32-4498-B853-96B694C61876Q48878340-1EAFA3AB-E184-42A6-A26C-F58988525EAAQ52098195-2DEBC8CA-5A02-4E02-A666-0425E08E905AQ55463876-63878A86-53C1-4B3C-A8C5-C991FB9944C3
P2860
Cerebral arteriopathy in children with neurofibromatosis type 1.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cerebral arteriopathy in children with neurofibromatosis type 1.
@ast
Cerebral arteriopathy in children with neurofibromatosis type 1.
@en
type
label
Cerebral arteriopathy in children with neurofibromatosis type 1.
@ast
Cerebral arteriopathy in children with neurofibromatosis type 1.
@en
prefLabel
Cerebral arteriopathy in children with neurofibromatosis type 1.
@ast
Cerebral arteriopathy in children with neurofibromatosis type 1.
@en
P2093
P356
P1433
P1476
Cerebral arteriopathy in children with neurofibromatosis type 1.
@en
P2093
Daune MacGregor
Derek Armstrong
Gabrielle deVeber
John F Brandsema
Patricia C Parkin
Rand Askalan
William J Logan
P304
P356
10.1542/PEDS.2009-0152
P407
P577
2009-08-24T00:00:00Z